-
公开(公告)号:US09445759B1
公开(公告)日:2016-09-20
申请号:US13726539
申请日:2012-12-24
Applicant: Cercacor Laboratories, Inc.
Inventor: Marcelo M. Lamego , Massi Joe E. Kiani , Jesse Chen , Mathew Paul , Hoi Wong
IPC: A61B5/1455 , A61B5/1495 , A61B5/0205 , A61B5/026 , A61B5/145 , A61B5/15
CPC classification number: A61B5/1495 , A61B5/0205 , A61B5/0261 , A61B5/14532 , A61B5/1455 , A61B5/150358 , A61B2560/0223 , A61B2562/0295
Abstract: A blood glucose calibration system has a noninvasive sensor that attaches to a person's tissue site so as to generate multi-stream physiological data responsive to that person's blood constituents. Composite parameters, each in the form of a mathematical combination of invasive blood panel parameters, are derived from a general population and are responsive to the multi-stream physiological data. A population-based, blood glucose estimate for that person is derived from a weighted and scaled combination of these composite parameters. An individualized blood glucose estimate is then derived from the population-based blood glucose estimate and intermittent invasive test strip measurements of that particular individual.
Abstract translation: 血糖校准系统具有附着于人的组织部位的无创传感器,以产生响应于该人血液成分的多流生理数据。 复合参数,各自以侵入性血液面板参数的数学组合的形式,从一般群体导出,并响应于多流生理数据。 该人的基于人群的血糖估计来自这些复合参数的加权和缩放组合。 然后从基于群体的血糖估计和该特定个体的间歇性侵入性测试条测量得到个体化的血糖估计值。